Home Tags Medicine
medicine Related Content
Here, we look at MRI research on brain abnormalities that could be the biological reason behind depression.
Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.
Here, we discover that the European Medicines Agency works to foster scientific excellence in the evaluation and supervision of medicines for the benefit of public and animal health in the European Union.
In the view of Amanda Feilding, Founder of the Beckley Foundation, “Psychedelics are unique pharmacological compounds that hold the promise of a profound paradigm shift in psychiatry.” Here, we learn about the Psychedelic Renaissance and the importance of drug policy reform.
Brendan Crossey, Chief Executive Officer of Healthcare Analytics Limited, directs our thoughts to innovative bed tracking at the Northern Health and Social Care Trust, one of five health and social care trusts in Northern Ireland.
Rich Pugh, Chief Data Scientist at Mango Solutions, discusses how data science can be used for good, with a particular focus on the provision of medication and helping create a more efficient NHS.
PTC Therapeutics have announced the use of a blood test for the rare genetic condition, aromatic L-amino acid decarboxylase (AADC) deficiency.
Only 11% of Brits see antimicrobial resistance as a serious threat to society, despite the outgoing UK Chief Medical Officer saying earlier this year that Superbugs “could kill us before climate change does”.
Charles Kinney, Communications Manager, EFA, argues that the policymakers have a long way to go addressing the reality of life with asthma and COPD.
Ewan Birney, Director of EMBL’s European Bioinformatics Institute (EMBL-EBI), reveals how genomics could improve healthcare and pave the way to precision medicine.
Swarms of nanoparticles which are 15,000 times smaller than a pinhead may be able to deliver vital drugs to the brain, offering new hope to stroke patients.
Here, Human Rights Watch discuss how United Arab Emirates (UAE) prison authorities are limiting access to HIV treatment for non-national prisoners.
England’s top doctor has welcomed public support for NHS proposals on fast treatment for those who need it in A&E.
NHS England has announced it has secured a definitive cystic fibrosis drugs agreement with Vertex Pharmaceuticals, to use all three of their UK-licensed medicines.
Here we find out how The Japanese Society of Nephrology engages in research developing human resources, providing lifelong education and disseminating knowledge to the public, to tackle kidney disease and promote health.
The NHS could save £300 million over the next 3 years as Phase 4 of the Electronic Prescription Service (EPS) is rolled out across the country.
Cosmo Feilding Mellen, Managing Director of Spectrum Therapeutics UK looks at access to medical cannabis and to what extent is medical cannabis now legalised.
After a career spanning more than 20 years, a Swansea University Professor’s passion for research is as ‘strong as ever’, as he marks a very notable achievement – the release of his 100th cancer research paper.
In the second of a series of five articles, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine.
Using cross-disciplinary technology, Dr Kunio Matsumoto, PhD, Professor at Kanazawa University in Japan is extending research on growth factor toward synthetic biologics for regeneration-based medicine and cancer theranostics.